Efgartigimod Offers Hope in Chronic Inflammatory Demyelinating Polyneuropathy Subcutaneous formulation lowers relapse risk in debilitating autoimmune disorder Nov 05, 2023
Rozanolixizumab Maintains Efficacy Among Generalized Myasthenia Gravis Subgroups Benefits maintained after multiple treatment cycles Nov 03, 2023
Novel C1s Inhibitor Shows Promising Activity in Rare Neurologic Disorder 44% of treated patients with CIDP showed improvement after switching to riliprubart Nov 03, 2023
Eculizumab Substantially Reduces Myasthenia Gravis Events Hospitalization dropped threefold, real-world data show Nov 02, 2023
Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosis Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge Nov 02, 2023
Lambert-Eaton Myasthenic Syndrome Underdiagnosed Alongside SCLC in the U.S. Findings suggest patients with SCLC are not screened for LEMS, despite their association Nov 02, 2023
Year in Review: Huntington's Disease New drug approved for chorea, and more insights about understanding the disease this year Nov 01, 2023
Probe of Alzheimer's Researcher Halted; Dementia and Triglycerides; Migraine Genes News and commentary from the world of neurology and neuroscience Oct 31, 2023
Dementia Risk Rises When Deep Sleep Falls Longitudinal study points to relationship in older adults over 12-year follow-up Oct 31, 2023
Subcutaneous Alzheimer's Drug May Be on the Horizon Investigational version of lecanemab shows promise, but questions about safety persist Oct 27, 2023
Novel Corticosteroid Approved for Rare Disease Vamorolone gets a nod from FDA for Duchenne muscular dystrophy Oct 27, 2023
Alzheimer's Pathology and COVID; Human Brain Cell Maps Unveiled; TCE Ban Proposed News and commentary from the world of neurology and neuroscience Oct 24, 2023
Widespread Selenium Deficiency Seen in Huntington's Disease Brains Researchers caution about self-medicating Oct 24, 2023
I'm a Neurosurgeon. Social Media May Change Your Kid's Brain. TikTok and Instagram are among the worst Oct 21, 2023
S1P Receptor Modulator May Boost Cognitive Processing Speed in Early MS Ozanimod led to test score improvements in interim analysis Oct 19, 2023
BTK Inhibitor Reduces Brain Lesions in Relapsing MS Subgroup analysis shows brain penetration Oct 19, 2023
Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kids These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
Neurofilament Light Predicts MS Worsening in Silent Progression NfL changes occurred in advance of, not coincident with, clinical worsening Oct 17, 2023
Subcutaneous Ocrelizumab Not Inferior to IV Infusion Both provided rapid B-cell depletion Oct 14, 2023
The Parasite Heard 'Round the World A wriggling worm in a woman's brain underscores parasites' indomitable will to survive Oct 14, 2023
Novel Drug Shows Promise in Multiple Sclerosis CD40 ligand inhibitor leads to sustained reduction of MRI disease activity Oct 13, 2023
Tamoxifen Fails to Deliver on Clinical Promise for Duchenne Muscular Dystrophy Phase III trial finds that repurposed tamoxifen was safe but ineffective Oct 10, 2023
Parkinsonism Case Tied to Welding, Improved With Chelation How one team pinpointed manganese toxicity and diminished a patient's motor symptoms Oct 04, 2023
COVID Vaccine, Infection May Affect Migraine Course Slightly Researchers compared headache diary data before and after vaccination or infection Oct 04, 2023
Chronic Stress and Dementia; Hormones and Brain Health; Dementia Protection Neurons? News and commentary from the world of neurology and neuroscience Oct 03, 2023
Loneliness Tied to Subsequent Parkinson's Risk Findings support Surgeon General's recent call to improve social connection Oct 02, 2023
New Option OK'd for Pompe Disease FDA approves two-component therapy for patients not improving on enzyme replacement therapy Sep 29, 2023
FDA Panel Overwhelmingly Rejects ALS Cell Therapy Echoing concerns from agency reviewers, advisors can't find evidence of efficacy Sep 28, 2023
Theory Slammed as Pseudoscience; TBI and Cardiovascular Risk; AAN Shares Its Vision News and commentary from the world of neurology and neuroscience Sep 26, 2023
FDA Staff Voice Serious Concerns About Investigational ALS Cell Therapy Data are "scientifically incomplete" and manufacturing info is "grossly deficient" Sep 25, 2023
Long COVID Blood Tests Show Distinct Immune and Hormone Function Algorithm may help predict who gets long COVID Sep 25, 2023
Blood, CSF Marker Detects Parkinsonian Disorders Enzyme also identified preclinical Lewy body disease Sep 20, 2023
Acrylic Window to the Brain; Chronic Fatigue Discovery; AI Spots Parkinson's Risk News and commentary from the world of neurology and neuroscience Sep 19, 2023
Many Medicare Patients Travel 50-Plus Miles for Neurology Visits Telemedicine can improve access to care, researchers argue Sep 15, 2023
Stroke Doesn't Have to Lead to Death or Disability Rapid, appropriate treatment can save lives and limit severe outcomes Sep 15, 2023
Huntington's Disease More Severe in Black Patients at Baseline Outreach to families of minority patients may help identify genetic disorder Sep 14, 2023
Dementia Risk Tied to Sedentary Lifestyle Ten hours or more a day of sedentary behavior raised risk of incident dementia Sep 12, 2023
Telomeres and Dementia; Cell Therapy and Parkinson's; Next Up: In Utero Neurology News and commentary from the world of neurology and neuroscience Sep 12, 2023
Ravulizumab Showed Preclinical Promise for ALS. What Happened? Phase III trial terminated for futility Sep 11, 2023
